Pneumotox Online
v2.2
  • RSS Feed
  • Contact
  • News
  • Diagnosing DIRD
  • Browse
  • Available on AppStore Available on AppStore

The Drug-Induced Respiratory Disease Website

Philippe Camus, M.D.

Dijon, France

  • Home
  • Browse by »
  • Drugs
  • Patterns

Ipilimumab

4

I.m ILD with a granulomatous component

1
Last update : 02/05/2012
 
Search
Advanced search
Identify causative drugs
Diagnosing DIRD
1
Drug and radiation history
2
Drug singularity - Correct identification of the drug
3
Consistent timing of exposure v. onset of symptoms
4
Clinical, imaging, BAL, pathological pattern consistent with the specific drug
5
Careful exlusion of another cause
6
Remission of symptoms with removal of drug
7
Recurrence with rechallenge (rarely advisable)
8
Causality assessment
More detailed checklist
See also under
CTLA4 blocking immunotherapy
3
Immune checkpoint inhibitors (ICI) - ICI combinatorial Rx
5
Tremelimumab
1

Publications

Sarcoidosis complicating anti-cytotoxic T-lymphocyte-associated antigen-4 monoclonal antibody biotherapy.
The European respiratory journal 2013 Jan;41;246-7 2013 Jan
Pulmonary sarcoid-like granulomatosis induced by ipilimumab.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012 Jun 10;30;e156-9 2012 Jun 10
Sarcoidosis in a patient with metastatic melanoma sequentially treated with anti-CTLA-4 monoclonal antibody and selective BRAF inhibitor.
Anticancer research 2012 Apr;32;1355-9 2012 Apr
Anti-CTLA4 monoclonal antibody induced sarcoidosis in a metastatic melanoma patient.
Dermatology (Basel, Switzerland) 2009;218;69-70 2009

Powered by

  • ^
  • Contact
  • Cookies
  • About